Literature DB >> 28060184

Are Clinical Guidelines for the Management of Intraductal Papillary Mucinous Neoplasms Followed?: A Single-Center Analysis.

Parissa Tabrizian1, Yaniv Berger, Elisa Sefora Pierobon, Samantha Aycart, Pamela Argiriadi, Kezhen Fei, Gonzalo Carrasco-Avino, Daniel M Labow, Umut Sarpel.   

Abstract

OBJECTIVES: This study aimed to determine how frequently guidelines for the management of intraductal papillary mucinous neoplasms (IPMNs) are followed and establish factors associated with failure.
METHODS: Four hundred forty-five patients with radiographic diagnosis of IPMN 1 cm or greater between January 1, 2003 and January 1, 2013 were included. We defined failure of guideline adherence if the following occurred: (a) failure of acknowledgment of IPMN, (b) failure to undergo endoscopic ultrasound, (c) failure to undergo resection, or (d) failure to undergo at least 1 surveillance image within 2 years after diagnosis.
RESULTS: Failure of guideline adherence was observed in 58% of patients and evident across all the respective criteria (A: 38%, B: 25%, C: 29%, D: 33%). Age older than 68 years (P < 0.01), American Society of Anesthesiologists score of 3 or higher (P < 0.0001), benign findings on imaging (P < 0.0001), and major comorbid conditions (P < 0.01) were factors associated with higher rate of failure to compliance. On multivariate logistic regression, American Society of Anesthesiologists score of 3 or higher and benign features were associated with 4.0 times (95% confidence interval, 2.02-8.06) and 2.6 times (95% confidence interval, 1.60-4.07) higher odds of failure to compliance with guidelines, respectively.
CONCLUSIONS: Compliance with clinical guidelines for the management of IPMN is poor. Socioeconomic factors do not seem to create a disparity to care. However, many patients with IPMN have other medical diagnoses that take priority over IPMN surveillance and treatment.

Entities:  

Mesh:

Year:  2017        PMID: 28060184      PMCID: PMC5990256          DOI: 10.1097/MPA.0000000000000747

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  19 in total

Review 1.  Cystic neoplasms of the pancreas.

Authors:  William R Brugge; Gregory Y Lauwers; Dushyant Sahani; Carlos Fernandez-del Castillo; Andrew L Warshaw
Journal:  N Engl J Med       Date:  2004-09-16       Impact factor: 91.245

Review 2.  Pancreatic cystic neoplasms: diagnosis and management.

Authors:  Won Jae Yoon; William R Brugge
Journal:  Gastroenterol Clin North Am       Date:  2012-01-20       Impact factor: 3.806

3.  Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.

Authors:  Klaus Sahora; Mari Mino-Kenudson; William Brugge; Sarah P Thayer; Cristina R Ferrone; Dushyant Sahani; Martha B Pitman; Andrew L Warshaw; Keith D Lillemoe; Carlos F Fernandez-del Castillo
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

Review 4.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

5.  Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging.

Authors:  Koen de Jong; Chung Y Nio; Banafsche Mearadji; Saffire S Phoa; Marc R Engelbrecht; Marcel G Dijkgraaf; Marco J Bruno; Paul Fockens
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

Review 6.  Quality assessment of the guidelines on cystic neoplasms of the pancreas.

Authors:  Massimo Falconi; Stefano Crippa; Suresh Chari; Kevin Conlon; Sun-Whe Kim; Philippe Levy; Masao Tanaka; Jens Werner; Christopher L Wolfgang; Raffaele Pezzilli; Carlos Fernandez-Del Castillo
Journal:  Pancreatology       Date:  2015-06-12       Impact factor: 3.996

7.  Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?

Authors:  Roberto Salvia; Stefano Crippa; Massimo Falconi; Claudio Bassi; Alessandro Guarise; Aldo Scarpa; Paolo Pederzoli
Journal:  Gut       Date:  2006-11-24       Impact factor: 23.059

8.  Current trends in pancreatic cystic neoplasms.

Authors:  Cristina R Ferrone; Camilo Correa-Gallego; Andrew L Warshaw; William R Brugge; David G Forcione; Sarah P Thayer; Carlos Fernández-del Castillo
Journal:  Arch Surg       Date:  2009-05

9.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  3 in total

1.  Pancreatic cystic neoplasms: Adherence to management recommendations and associated endosonographic cyst characteristics.

Authors:  Athanasios Sioulas; Marianna Spinou; Dimitrios Schizas; Maria Megapanou; Maximos Frountzas; Konstantina Papadaki; Ilias Scotiniotis
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

2.  Factors affecting the rates of adherence to surveillance recommendations for incidental pancreatic cystic lesions in a large urban safety net hospital.

Authors:  Andrew Canakis; Asaf Maoz; Jaroslaw N Tkacz; Christopher Huang
Journal:  BMJ Open Gastroenterol       Date:  2020-07

3.  Current trends in the management of pancreatic cystic neoplasms in Korea: a national survey.

Authors:  Hyung Ku Chon; Sung Hoon Moon; Sang Wook Park; Woo Hyun Paik; Chang Nyol Paik; Byoung Kwan Son; Tae Jun Song; Dong Won Ahn; Eaum Seok Lee; Yun Nah Lee; Yoon Suk Lee; Jae Min Lee; Tae Joo Jeon; Chang-Hwan Park; Kwang Bum Cho; Dong Wook Lee
Journal:  Korean J Intern Med       Date:  2021-07-29       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.